Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Non-cash Items: 2012-2024

Historic Non-cash Items for Cytokinetics (CYTK) over the last 13 years, with Dec 2024 value amounting to $6.9 million.

  • Cytokinetics' Non-cash Items fell 5.50% to $6.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.9 million, marking a year-over-year decrease of 5.50%. This contributed to the annual value of $6.9 million for FY2024, which is 5.50% down from last year.
  • Cytokinetics' Non-cash Items amounted to $6.9 million in FY2024, which was down 5.50% from $7.3 million recorded in FY2023.
  • In the past 5 years, Cytokinetics' Non-cash Items ranged from a high of $302.1 million in FY2021 and a low of $6.2 million during FY2022.
  • Over the past 3 years, Cytokinetics' median Non-cash Items value was $6.9 million (recorded in 2024), while the average stood at $6.8 million.
  • Per our database at Business Quant, Cytokinetics' Non-cash Items skyrocketed by 1,618.03% in 2020 and then tumbled by 97.96% in 2022.
  • Cytokinetics' Non-cash Items (Yearly) stood at $91.9 million in 2020, then spiked by 228.73% to $302.1 million in 2021, then slumped by 97.96% to $6.2 million in 2022, then rose by 18.29% to $7.3 million in 2023, then dropped by 5.50% to $6.9 million in 2024.